Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Bacterial infection

Bacterial infection

5 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Bacterial infection

17 trials tracked for Bacterial infection: 4 in phase 3 or 4.

17Trials tracked
4Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 2 Phase 3 2 Phase 2 5 Phase 1 3 Other / NA 5
  1. Phase 4 Minocycline Pharmacokinetics (ACUMIN) Completed
  2. Phase 4 Bioequivalence Between Two Tablet Formulations Of Doxycycline Carragenate Completed
  3. Phase 3 Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation Completed
  4. Phase 3 Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant Completed
  5. Phase 2 Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings Completed
  6. Phase 2 A Trial to Evaluate the Pharmacokinetics and Safety of AVYCAZ(R) in Combination With Aztreonam Completed
Show 11 more trials
  1. Phase 2 Addition of Probenecid to Penicillin-V Therapy Completed
  2. Phase 2 Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections Completed
  3. Phase 2 Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites Completed
  4. Phase 1 Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777) Completed
  5. Phase 1 Intravenous Fosfomycin Pharmacokinetics Study Completed
  6. Phase 1 Safety of Intravenous Apramycin in Adults Completed
  7. N/A Larval Debridement Therapy Versus Sharp Debridement to Remove Biofilm Completed
  8. N/A Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on Hemodialysis Completed
  9. N/A Trial to Reduce Antimicrobial Use In Nursing Home Residents With Alzheimer's Disease and Other Dementias Completed
  10. N/A Study of the Pharmacokinetics of Daptomycin in Children With Renal Disease Completed
  11. N/A Antibiotic Selection Using Next Generation Sequencing vs Urine Culture Completed

Showing the 17 most-cited and recently-updated of 17 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Fungal biotransformation platform may generate new anti-infective molecules to combat antimicrobial resistance
Infectious Disease Sys. Review
Fungal biotransformation platform may generate new anti-infective molecules to combat antimicrobial resistance Fungal Biotransformation May Help Combat Antimicrobial Resistance
This narrative review discusses fungal biotransformation as a discovery platform for generating structurally refined metabolites with anti-i…
New research explores how fungal systems can transform chemicals into new molecules to help fight stubborn bacterial and fungal infections.
Frontiers Jun 10, 2026
Review of influenza A and secondary bacterial infections identifies critical knowledge gaps
Infectious Disease Sys. Review
Review of influenza A and secondary bacterial infections identifies critical knowledge gaps Review highlights gaps in flu and secondary infection care
This is a narrative review on influenza A virus infection, secondary bacterial infection, and nosocomial infection. The authors synthesize c…
A new review points out major missing knowledge about flu and related infections. It calls for more research to help patients.
Frontiers May 25, 2026
Meta-analysis shows association between adequate antimicrobial therapy and reduced hospital length of stay
Infectious Disease Meta-analysis
Meta-analysis shows association between adequate antimicrobial therapy and reduced hospital length of stay Right Antibiotic Choice Cuts Hospital Stay by Nearly Two Weeks
This meta-analysis of 4158 adult hospitalised patients examines the relationship between adequate empirical antibiotic therapy and clinical …
Choosing the right antibiotic from the start can cut a hospital stay by nearly two weeks for adults with serious infections.
May 2, 2026
Early-oral antibiotics showed safety superiority and efficacy equivalence versus IV-only in patients requiring prolonged therapy
Infectious Disease RCT
Early-oral antibiotics showed safety superiority and efficacy equivalence versus IV-only in patients requiring prolonged therapy Switching to oral antibiotics early cut side effects for rural patients
This randomized controlled trial evaluated patients requiring two or more weeks of IV antibiotics for infections excluding central nervous s…
Patients needing IV antibiotics for weeks had fewer side effects when they switched to oral meds early. This trial in a rural health system …
May 1, 2026
Nanochitosan-coated NiTi archwires reduced bacterial CFUs versus uncoated controls in a small RCT
Infectious Disease RCT
Nanochitosan-coated NiTi archwires reduced bacterial CFUs versus uncoated controls in a small RCT New Coating Slashes Cavity-Causing Bacteria on Braces
This randomized controlled trial enrolled 30 patients in an oral cavity setting.
This new wire coating could help millions with braces keep their teeth healthy.
Apr 23, 2026

Questions about Bacterial infection

Is there a link between influenza and secondary bacterial infection?

Yes, influenza significantly increases the risk of secondary bacterial infections, such as pneumonia from Streptococcus pneumoniae or Staphylococcus aureus, due to immune dysregulation and epithelial damage.

Full answer →